INDUSTRY PROFILE
Synthetic biology manufacturers reprogram microorganisms to produce chemicals, materials, and therapeutics that traditional chemistry cannot deliver economically or sustainably. The industry is an applied extension of academic research in metabolic engineering, systems biology, and molecular genetics — disciplines that generate the majority of its technical workforce. Companies like Ginkgo Bioworks and Solugen recruit heavily from PhD programs, open-source consortia, and iGEM alumni networks. Academic intelligence platforms allow these companies to track publication activity around specific genetic circuits, promoter libraries, or biosensor designs, giving recruiting and business-development teams a first-mover advantage when novel academic discoveries are about to translate to industry.
MARKET SIZE
$55B
KEY COMPANIES
10
TARGET RESEARCHERS
Synthetic biologists, metabolic engineers, and bioinformaticians working on strain design, CRISPR toolkits, and fermentation scale-up
KEY COMPANIES
Ginkgo Bioworks
Zymergen
Pivot Bio
Arcturus Biotherapeutics
Inscripta
Asimov
Twist Bioscience
Colossal Biosciences
Solugen
LanzaTech
USE CASES
Metabolic-engineering PhD recruitment for strain-design teams
University partnerships for novel biosynthetic pathway discovery
CRISPR base-editing tool licensing and collaborations
Fermentation scale-up talent pipeline from chemical-engineering programs
Bioinformatics and design-of-experiments workflow development
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED